SCHEMBL3479595

SCHEMBL3479595

CN1CCN(c2ccc3ccccc3c2)c2ccc(-n3cncn3)cc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 2/20 0.44
WNT1 P04628 1/20 0.39
DYRK1A Q13627 1/20 0.39
SCN9A Q15858 1/20 0.37
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
HRH4 Q9H3N8 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
ROCK2 O75116 1/20 0.35
CYP17A1 P05093 1/20 0.35
HTR6 P50406 3/20 0.34
HTR1A P08908 2/20 0.34
HTR2A P28223 2/20 0.34
HTR7 P34969 2/20 0.34
DRD2 P14416 1/20 0.34
NR1D1 P20393 1/20 0.33
BRD4 O60885 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479558 0.89 SCN9A (0.39) WNT1DYRK1ASCN9APRMT5WDR77
SCHEMBL3479681 0.83 BRD4 (0.36) WNT1DYRK1ASCN9AROCK2BRD4
SCHEMBL3479528 0.83 HTR3A (0.45) HTR3ASCN9AHRH4CYP17A1HTR6
SCHEMBL3479654 0.83 BRD4 (0.48) WNT1DYRK1ASCN9AROCK2BRD4
SCHEMBL3217500 0.83 HSD11B1 (0.39) WNT1DYRK1ASCN9AHRH4TSHR
SCHEMBL3229454 0.82 HSD11B1 (0.36) WNT1DYRK1ASCN9APRMT5WDR77
SCHEMBL3233131 0.80 HTR3A (0.51) HTR3ASCN9AHPGDTSHRHTR6
SCHEMBL3479750 0.79 HTR3A (0.45) HTR3ASCN9ACYP17A1HTR6HTR1A
SCHEMBL3227692 0.78 HTR3A (0.58) HTR3AHPGDTSHR
SCHEMBL3227778 0.78 HTR3A (0.51) HTR3ASCN9AHPGDTSHRHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D HTR3A 30/4885WNT1 2258/4885DYRK1A 771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.